The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and Research, the agency said on Tuesday.
Trending
- PwC graduate roles under threat from AI, accountancy firm boss says
- Waarom elke dag de schoen zetten geen goed idee is: ‘Als je nu al hysterisch begint, zit je er jaren aan vast’
- Prostate cancer screening trial to recruit thousands of men
- Government borrowing third-highest record in October as people not spending – official figures | Money News
- Households face surprise rise in prices in new year
- Was our moon made by Earth colliding with its neighbor? – DW – 11/20/2025
- Cristiano Ronaldo attends White House meeting and dinner with Donald Trump
- Palestine plays first-of-a-kind football friendly in Spain – DW – 11/17/2025
